95 related articles for article (PubMed ID: 4338981)
1. Immunogenicity of highly purified -toxoid of Clostridium perfringens.
Sato H; Kameyama S; Murata R
Jpn J Med Sci Biol; 1972 Feb; 25(1):53-6. PubMed ID: 4338981
[No Abstract] [Full Text] [Related]
2. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI
Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638
[No Abstract] [Full Text] [Related]
3. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
[TBL] [Abstract][Full Text] [Related]
4. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
[TBL] [Abstract][Full Text] [Related]
5. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
[TBL] [Abstract][Full Text] [Related]
6. [Toxoids from the venom of Habu (Trimeresurus flavoviridis). II. Immunogenicity of the purified toxoids].
Sadahiro S
Nihon Saikingaku Zasshi; 1971 Jul; 26(7):319-24. PubMed ID: 5107268
[No Abstract] [Full Text] [Related]
7. Antitoxin response in cattle vaccinated with Clostridium perfringens type C toxoid.
Kennedy KK; Norris SJ; Beckenhauer WH; White RG
Vet Med Small Anim Clin; 1977 Jul; 72(7):1213-5. PubMed ID: 196381
[No Abstract] [Full Text] [Related]
8. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
Ito A
Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
[No Abstract] [Full Text] [Related]
9. Antitoxin titer in colostrum and milk after vaccination of sows with Clostridium perfringens type C toxoid vaccine.
Djurickovic SM; Dworak JE; Wickham KL
Vet Med Small Anim Clin; 1975 Mar; 70(3):283-5. PubMed ID: 164076
[No Abstract] [Full Text] [Related]
10. [Use of the passive hemagglutination test for the purpose of determining antibody levels following animal immunization with Cl. perfringens toxoid].
Shemanova GF; Dmitrieva LN; Vlasova EV; Panteleev EI; Moshiashvili IIa
Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):85-8. PubMed ID: 193324
[TBL] [Abstract][Full Text] [Related]
11. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea.
Walker PD; Foster WH; Knight PA; Freestone DS; Lawrence G
J Biol Stand; 1979; 7(4):315-23. PubMed ID: 231605
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of pregnant sows with Clostridium perfringens type C toxoid.
Kennedy KK; Norris SJ; Beckenhauer WH; Hogg A
Vet Med Small Anim Clin; 1977 Jun; 72(6):1047-9. PubMed ID: 194385
[No Abstract] [Full Text] [Related]
13. Antibody formation in mice in various genotypes after immunization with highly purified perfringens alpha-toxoid.
Petrov RV; Shemanova GF; Panteleyev EI; Dmitriyeva LN
Arch Roum Pathol Exp Microbiol; 1976 Dec; 35(4):311-6. PubMed ID: 199137
[No Abstract] [Full Text] [Related]
14. SPECIFIC PRECOCIOUS PROTECTIVE ACTION OF TOXOIDS.
MELLANBY J; VANHEYNINGEN WE
Nature; 1964 Jul; 203():312-3. PubMed ID: 14201781
[No Abstract] [Full Text] [Related]
15. [Immunization against gas gangrene and tetanus with sexta-anatoxin (in experiments with animals)].
Vlasova EV; Larina IA
Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):113-6. PubMed ID: 4315881
[No Abstract] [Full Text] [Related]
16. Purification of Clostridium toxoids.
Buchowicz I; Hay M; Schiller B; Korbecki M; Sochańska R
Acta Microbiol Pol; 1977; 26(3):285-94. PubMed ID: 70974
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of cattle and sheep with a combined Clostridium perfringens types C and D toxoid.
Kennedy KK; Norris SJ; Beckenhauer WH; White RG
Am J Vet Res; 1977 Oct; 38(10):1515-7. PubMed ID: 201186
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of purified Habu snake-venom toxoid in guinea pigs and monkeys with special reference to HR1 component.
Sadahiro S; Omori-Satoh T; Yamauchi K; Kondo S; Ishida S; Murata R
Jpn J Med Sci Biol; 1981 Aug; 34(4):213-30. PubMed ID: 6798252
[TBL] [Abstract][Full Text] [Related]
19. [Properties of C1. perfringens toxoids obtained from purified toxins].
Dmitrieva LN; Shemanova GF; Vlasova EV; Akhundova KA
Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):110-4. PubMed ID: 868405
[TBL] [Abstract][Full Text] [Related]
20. [Homogeneous Cl. perfringens alpha-anatoxin: its physicochemical and immunogenic properties].
Shemanova GF; Petrov RV; Dmitrieva LN; Panteleev EI; Drachev VA
Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):117-22. PubMed ID: 208330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
